WFM
IMMU

Wilmington Funds Management’s Immunomedics Inc IMMU Stock Holding History

Wilmington Funds Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-97,750
Closed -$605K – 838
2013
Q3 		$605K Buy
+97,750
New +$563K 0.06% 332

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Wilmington Funds Management's IMMU Position: Q4 2013 in Review

Wilmington Funds Management sold out of Immunomedics Inc (IMMU) in Q4 2013, closing a stake of 97,750 shares — an estimated $605K sold.

Wilmington Funds Management first reported a position in IMMU in Q3 2013 and held it in 1 quarter. The position peaked at $605K in Q3 2013. 81 funds tracked by Wall St. Rank hold IMMU as of Q4 2013.

  • Wilmington Funds Management reported no remaining Immunomedics Inc position as of Q4 2013 after selling out during the quarter.
  • Wilmington Funds Management sold 97,750 Immunomedics Inc shares in Q4 2013, an estimated $605K.
  • Wilmington Funds Management first reported a position in Immunomedics Inc in Q3 2013 and held it in 1 quarter.
  • Wilmington Funds Management's Immunomedics Inc position peaked at $605K in Q3 2013.
  • 81 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2013.

Based on Wilmington Funds Management's 13F filing for Q4 2013, filed 12 Feb 2014.